Open menu
Paytm Money logo
UTI Mutual Fund

UTI Healthcare Fund Direct-Growth

NAV
returns change indicator
84.2836
as on 18 Sep 2019 09:05 PM
0.2801(0.33%)
Last Change
loaderloader
Schemes Managed By
Investment Performance
would have given a returns of
110,871
star
121,647
star
83,232
star
87,768
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
12,232
Profit (absolute return)
12.23%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
2.02%
In the last 6 months
4.24%
In the last 1 year
14.37%
In the last 3 years
12.23%
In the last 5 years
5.18%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth
as of 18 Sep 2019 09:05 PM
384.37 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed less than 1 year
1.76%
Expense Ratio
Plan
Growth
3.90%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed less than 1 year
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
94.52%
363.30 Cr
Cash Holding
3.90%
14.99 Cr
Financial
1.54%
5.92 Cr
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
94.52%
363.30 Cr
Cash Holding
3.90%
14.99 Cr
Financial
1.54%
5.92 Cr
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
11.98%
46.05 Cr
Divi's Laboratories Ltd.
9.33%
35.86 Cr
Lupin Ltd.
8.31%
31.94 Cr
Dr. Reddy's Laboratories Ltd.
7.30%
28.06 Cr
Cipla Ltd.
6.77%
26.02 Cr
Ipca Laboratories Ltd.
6.00%
23.06 Cr
Cadila Healthcare Ltd.
5.98%
22.99 Cr
Aurobindo Pharma Ltd.
4.89%
18.80 Cr
Sanofi India Ltd.
4.83%
18.56 Cr
Others
3.90%
14.99 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
11.98%
46.05 Cr
Divi's Laboratories Ltd.
9.33%
35.86 Cr
Lupin Ltd.
8.31%
31.94 Cr
Dr. Reddy's Laboratories Ltd.
7.30%
28.06 Cr
Cipla Ltd.
6.77%
26.02 Cr
Ipca Laboratories Ltd.
6.00%
23.06 Cr
Cadila Healthcare Ltd.
5.98%
22.99 Cr
Aurobindo Pharma Ltd.
4.89%
18.80 Cr
Sanofi India Ltd.
4.83%
18.56 Cr
Others
3.90%
14.99 Cr
View All
View All
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager V Srivatsa. It has an AUM of ₹384.37 Crores and the latest NAV decalared is ₹84.284 as on 18 Sep 2019 at 9:05 pm.
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is -14.37%, in last 3 years is -12.23% and 76.62% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
AUM:384.37 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
AMC Information
UTI Mutual Fund
UTI Mutual Fund
View AMC Details
148,712.72 Cr
AUM
200
Schemes
Address
Address
UTI Tower, 'GN' Block,Bandra-Kurla Complex,Bandra (East),400051
Phone Number
Phone Number
Phone : 022- 66786666 / 66786354 / 1800-22-1230
Fax : 022-26523031